Just 24 Weeks to Cure Hepatitis C
Using response-guided therapy, the new three drug regimen can cure Hepatitis C in just six months.
Continue reading »Using response-guided therapy, the new three drug regimen can cure Hepatitis C in just six months.
Continue reading »Upon identifying weaknesses in the Hepatitis C virus, Australian researchers believe their discovery could lead to a vaccine.
Continue reading »With the recent approval of the direct acting antivirals (DAA) Incivek and Victrelis, Hepatitis C treatment is improving. However, the next crop of DAAs has the potential to make Hepatitis C treatment even better.
Continue reading »Showing potential to be a monotherapy for chronic Hepatitis C infection, the FDA has awarded Pharmasset with fast track status for its drug in development, PSI-938.
Continue reading »For people new to treatment and those who have failed a previous treatment attempt, Vertex's Incivek can now be prescribed to Canadians with chronic Hepatitis C.
Continue reading »Hepatitis C patients in the UK can now increase their odds of beating the virus with Victrelis.
Continue reading »In animal subjects, French researchers developing a preventive Hepatitis C vaccine announced success; hopefully human trials will follow.
Continue reading »In a trial called Zenith, Vertex finds that a combination of four drugs knocked out Hepatitis C in half of participants in just 12 weeks.
Continue reading »Just like any drug, the two newly approved medications for Hepatitis C have side effects.
Continue reading »Representing the European Union's first approved Hepatitis C drug in a decade, Victrelis (boceprevir) can now be used in Europe to battle the most persistent strain of this prevalent liver virus.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window